Previous close | 2.5600 |
Open | 2.6000 |
Bid | 2.5600 x 400 |
Ask | 2.5900 x 200 |
Day's range | 2.5600 - 2.6701 |
52-week range | 1.9100 - 29.5600 |
Volume | |
Avg. volume | 1,484,393 |
Market cap | 78.582M |
Beta (5Y monthly) | 0.39 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
BioXcel Therapeutics ( NASDAQ:BTAI ) Full Year 2023 Results Key Financial Results Net loss: US$179.1m (loss widened by...
BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q4 2023 Earnings Call Transcript March 12, 2024 BioXcel Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.76, expectations were $-0.98. BioXcel Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome […]
Q4 2023 BioXcel Therapeutics Inc Earnings Call